abstract |
The present invention is directed to diabetic or non-diabetic patients, including certain DPP-4 inhibitors for treating and / or preventing oxidative stress, vascular stress and / or endothelial dysfunction and groups of patients at risk for cardiovascular and / or kidney disease. The use of said DPP-4 inhibitor in the treatment and / or prophylaxis of |